| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000045748 |
| Receipt No. | R000052225 |
| Scientific Title | Verification of the effectiveness of a Unilateral space neglect treatment support system using MR |
| Date of disclosure of the study information | 2021/10/14 |
| Last modified on | 2021/10/14 (Ver. 1) |
| Basic information | ||
| Public title | Verification of the effectiveness of a Unilateral space neglect treatment support system using MR | |
| Acronym | Verification of the effectiveness of a Unilateral space neglect treatment support system using MR | |
| Scientific Title | Verification of the effectiveness of a Unilateral space neglect treatment support system using MR | |
| Scientific Title:Acronym | Verification of the effectiveness of a Unilateral space neglect treatment support system using MR | |
| Region |
|
|
| Condition | ||
| Condition | Unilateral spatial neglect | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Verification of the effect of applying the developed system on the improvement of neglect symptoms in daily life |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Catherine Bergego Scale
Time of assessment immediately before the intervention and immediately after the intervention |
| Key secondary outcomes | Behavioural inattention test
Slalom test Measuring neglected areas using immersive VR Time of assessment immediately before the intervention and immediately after the intervention |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Have the patient wear the HMD and present multiple holograms superimposed at shoulder height and on the ground in real space.
The patient moves around the rehabilitation space in a wheelchair or by walking while visually exploring the space. After recognizing the holograms, the patient touches the shoulder-level hologram with his/her hand or reads the text on the hologram. For holograms on the ground, touch them with the hand. This intervention will be conducted for 20 minutes a day for two weeks. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Unilateral spatial neglect patient
2.person who can perform a line erasure in the front midline without the assistance of a third party. 3. person who is not hemianopsia 4.person in the hyperacute stage or later, more than 2 weeks after the onset of illness 5. Hemiplegic stroke patients in a rehabilitation hospital |
|||
| Key exclusion criteria | 1. Uncontrolled heart failure
2. Acute myocardial infarction 3. Active myocarditis or pericarditis 4. Unstable angina 5. Acute systemic embolism or pulmonary embolism 6. Acute infection 7. Thrombophlebitis 8. Ventricular tachycardia or refractory ventricular arrhythmia 9. Severe ventricular outflow tract obstruction 10. Uncontrolled arterial or pulmonary hypertension 11. Those who are not capable of performing the tasks indicated in the test procedure (including breaks between tasks) 12. Those with obvious hemianopsia 13. Mini Mental State Examination (MMSE): 21 points or less (unless able to take and answer) 14. The very elderly (90 years old and above) 15. Functional Independent Measure (FIM) cognitive items: 20 points or less 16. Japan ComaScale (JCS) 3 digits or more Exclusion criteria are determined by the attending physician |
|||
| Target sample size | 28 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Waseda University | ||||||
| Division name | Faculty science and engineering | ||||||
| Zip code | 162-0042 | ||||||
| Address | Room 603, Green Computing Systems Research Organization, Building 40, Waseda University, 27 Waseda-cho, Shinjuku-ku, Tokyo | ||||||
| TEL | 03-3203-4427 | ||||||
| jubi@waseda.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Waseda University | ||||||
| Division name | Faculty science and engineering | ||||||
| Zip code | 162-0042 | ||||||
| Address | Room 603, GCS, Building 40, Waseda University, 27 Waseda-cho, Shinjuku-ku, Tokyo | ||||||
| TEL | 03-3203-4427 | ||||||
| Homepage URL | |||||||
| jubi@waseda.jp | |||||||
| Sponsor | |
| Institute | Waseda University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Waseda University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | medical corporation sonoda-kai sonoda-kai rehabilitation hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee of Waseda University |
| Address | 1-104 Totsuka-cho, Shinjyuku-ku, Tokyo 169-8050 |
| Tel | 03-5272-1639 |
| rinri@list.waseda.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団苑田会苑田会リハビリテーション病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052225 |